- Home
- IGC vs ACCS Comparison
IGC vs ACCS Comparison
Compare IGC & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- ACCS
- Stock Information
- Founded
- IGC 2005
- ACCS 1988
- Country
- IGC United States
- ACCS United States
- Employees
- IGC N/A
- ACCS N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- ACCS Publishing
- Sector
- IGC Health Care
- ACCS Consumer Discretionary
- Exchange
- IGC Nasdaq
- ACCS Nasdaq
- Market Cap
- IGC 39.8M
- ACCS 46.2M
- IPO Year
- IGC N/A
- ACCS N/A
- Fundamental
- Price
- IGC $0.42
- ACCS $10.88
- Analyst Decision
- IGC Strong Buy
- ACCS Strong Buy
- Analyst Count
- IGC 2
- ACCS 1
- Target Price
- IGC $4.00
- ACCS $14.00
- AVG Volume (30 Days)
- IGC 1.4M
- ACCS 10.7K
- Earning Date
- IGC 08-14-2025
- ACCS 11-06-2025
- Dividend Yield
- IGC N/A
- ACCS N/A
- EPS Growth
- IGC N/A
- ACCS N/A
- EPS
- IGC N/A
- ACCS N/A
- Revenue
- IGC $1,327,000.00
- ACCS $22,562,000.00
- Revenue This Year
- IGC $15.26
- ACCS $0.03
- Revenue Next Year
- IGC $3.41
- ACCS $11.45
- P/E Ratio
- IGC N/A
- ACCS N/A
- Revenue Growth
- IGC 24.95
- ACCS 26.44
- 52 Week Low
- IGC $0.25
- ACCS $7.79
- 52 Week High
- IGC $0.50
- ACCS $13.35
- Technical
- Relative Strength Index (RSI)
- IGC 55.05
- ACCS 44.96
- Support Level
- IGC $0.39
- ACCS $10.30
- Resistance Level
- IGC $0.47
- ACCS $11.00
- Average True Range (ATR)
- IGC 0.04
- ACCS 0.36
- MACD
- IGC 0.00
- ACCS 0.02
- Stochastic Oscillator
- IGC 43.67
- ACCS 53.70
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.